This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Lofepramine

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Lofepramine is a tetracyclic which is thought to be less cardiotoxic and to have fewer anticholinergic side-effects than the older tricyclics like imipramine.

The dose ranges from 70-210 mg per day.

It is degraded to desmethylimipramine, an active metabolite of imipramine, and so shares some of its properties.

The summary of product characteristics should be consulted before prescribing this drug.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.